Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Am J Otolaryngol. 2020 Oct 22;42(1):102780. doi: 10.1016/j.amjoto.2020.102780

Table III:

5-year Overall Survival in HPV-associated OPSCC adjusted for demographics, stage, tobacco, and alcohol

Addition of tobacco and alcohol use*

Hazard Ratio 95% CI P-Value
Black (vs. white) 4.1 1.5 – 11.4 0.007
Age Category (Relative to < 50)
 50–65 0.9 0.4 – 2.0 0.773
 65+ 1.4 0.5 – 3.9 0.531
Female sex (relative to male) 0.8 0.3 – 2.0 0.694
T Stage (relative to T1)
 T2 0.8 0.3 – 1.9 0.546
 T3 1.5 0.6 – 4.0 0.400
 T4 2.5 1.0 – 6.3 0.053
Nodal disease (relative to N0) 1.7 0.7 – 4.2 0.267
Distant Metastases (relative to M0) 4.6 0.6 – 36.5 0.154
Smoking (> 10 pack-years) 1.0 0.5 – 2.2 0.903
Alcohol use (any vs. none) 1.6 0.5 – 4.6 0.403
*

Model adjusted for race, age, sex, T stage, nodal disease, distant metastases, smoking, and alcohol use